Evidence map›Paper›PMID 39023446›Full record

ArticleFuture oncology (London, England)2024

TURALIO

Charles Dharmani, Oluwatosin Fofah, Maura Fallon, Abdul Waheed Rajper, Margaret Wooddell, Maribel Salas

Abstract read
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charles DharmaniGlobal Epidemiology, Daiichi Sankyo, Inc., Basking Ridge, NJ 07920, USA.ORCID 0000-0003-3641-9738
Oluwatosin FofahGlobal Epidemiology, Daiichi Sankyo, Inc., Basking Ridge, NJ 07920, USA.ORCID 0000-0003-2470-8276
Maura FallonClinical Safety & Pharmacovigilance, Daiichi Sankyo UK Ltd., Uxbridge, UB8 1DH, UK.ORCID 0009-0004-5948-8634
Abdul Waheed RajperClinical Safety & Pharmacovigilance, Daiichi Sankyo, Inc., Basking Ridge, NJ 07920, USA.ORCID 0009-0000-6468-7380
Margaret WooddellGlobal Oncology Medical Affairs, Daiichi Sankyo, Inc., Basking Ridge, NJ 07920, USA.ORCID 0009-0008-3657-6614
Maribel SalasGlobal Epidemiology, Daiichi Sankyo, Inc., Basking Ridge, NJ 07920, USA.ORCID 0000-0001-5634-1558

Funding

Daiichi Sankyo, Inc.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chemical and Drug Induced Liver InjuryAdultAgedAged, 80 and overFemaleHumansLiverMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk Evaluation and Mitigationadverse events (AEs)hepatotoxicitypexidartinibRisk Evaluation and Mitigation Strategy (REMS)tenosynovial giant cell tumor (TGCT)TURALIO®tyrosine kinase inhibitor

Identifiers

PMID39023446
PMCPMC11534110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.